SCHEMBL1861994

SCHEMBL1861994

CC(=O)NC(CO)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48989 0.87
SCHEMBL14970377 0.87
SCHEMBL5669163 0.87
SCHEMBL13397296 0.85 CRAT (0.42)
SCHEMBL12807817 0.85
SCHEMBL20244940 0.85
SCHEMBL2548083 0.85
SCHEMBL21338510 0.85
SCHEMBL11073459 0.83 ALDH1A1 (0.52)
SCHEMBL14294441 0.83 ALDH1A1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023220281-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COINFECTION WITH EIMERIA AND CLOSTRIDIUM CAN TECHNOLOGIES, INC. (US) 2023-11-16 WO disclosed
EP-4234634-A2 MODIFIED CYANINE DYES AND CONJUGATES THEREOF Bracco Imaging SPA (IT) 2023-08-30 EP disclosed
US-20230234978-A1 NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF Atrium Therapeutics, Inc. 2023-07-27 US disclosed
US-20230234978-A1 NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF Atrium Therapeutics, Inc. 2023-07-27 US disclosed
EP-3969063-B1 MODIFIED CYANINE DYES AND CONJUGATES THEREOF BRACCO IMAGING SPA (IT) 2023-07-05 EP disclosed
WO-2023072974-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-05-04 WO disclosed
US-11578090-B2 Nucleic acid-polypeptide compositions and uses thereof AVIDITY BIOSCIENCES, INC. (US) 2023-02-14 US disclosed
US-20210363165-A1 NITROXOLINE PRODRUG AND USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2021-11-25 US disclosed
CN-108530381-B Method for preparing diamine derivative from amide ester 上海科技大学 2021-09-21 CN disclosed
US-10869846-B2 N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress SENTIENT LIFESCIENCES, INC. (US) 2020-12-22 US disclosed
US-20050131016-A1 Chemical compounds ASTRAZENECA AB (SE) 2005-06-16 US disclosed
EP-1485371-A2 INDOLE AMIDE DERIVATIVES AND THEIR USE AS GLYCOGEN PHOSPHORYLASE INHIBITORS AstraZeneca AB (SE) 2004-12-15 EP disclosed
EP-1483270-A1 HETEROCYCLIC AMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE Astrazeneca AB (SE) 2004-12-08 EP disclosed
EP-1317459-B1 BICYCLIC PYRROLYL AMIDES AS GLUCOGEN PHOSPHORYLASE INHIBITORS ASTRAZENECA AB (SE) 2004-04-07 EP disclosed
US-20030232875-A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors ASTRAZENECA AB (SE) 2003-12-18 US disclosed
WO-2003074513-A2 INDOLE AMIDE DERIVATIVES AND THEIR USE AS GLYCOGEN PHOSPHORYLASE INHIBITORS ASTRAZENECA AB (SE) 2003-09-12 WO disclosed
WO-2003074532-A1 HETEROCYCLIC AMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE ASTRAZENECA AB (SE) 2003-09-12 WO disclosed
EP-1317459-A1 BICYCLIC PYRROLYL AMIDES AS GLUCOGEN PHOSPHORYLASE INHIBITORS AstraZeneca AB (SE) 2003-06-11 EP disclosed
WO-2002020530-A1 BICYCLIC PYRROLYL AMIDES AS GLUCOGEN PHOSPHORYLASE INHIBITORS ASTRAZENECA AB (SE) 2002-03-14 WO disclosed
WO-2001058848-A1 A PROCESS FOR THE PURIFICATION OF 3-AMINO-1,2-PROPANEDIOL AND 2-AMINO-1,3-PROPANEDIOL BRACCO IMAGING S.P.A. (IT) 2001-08-16 WO disclosed